Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Gross Profit: 2017-2025

Historic Gross Profit for Arcus Biosciences (RCUS) over the last 8 years, with Sep 2025 value amounting to $26.0 million.

  • Arcus Biosciences' Gross Profit fell 45.83% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.0 million, marking a year-over-year decrease of 8.75%. This contributed to the annual value of $258.0 million for FY2024, which is 120.51% up from last year.
  • According to the latest figures from Q3 2025, Arcus Biosciences' Gross Profit is $26.0 million, which was down 83.75% from $160.0 million recorded in Q2 2025.
  • Over the past 5 years, Arcus Biosciences' Gross Profit peaked at $354.6 million during Q4 2021, and registered a low of $9.5 million during Q1 2021.
  • In the last 3 years, Arcus Biosciences' Gross Profit had a median value of $31.0 million in 2023 and averaged $53.5 million.
  • Its Gross Profit has fluctuated over the past 5 years, first skyrocketed by 3,637.93% in 2021, then plummeted by 90.41% in 2022.
  • Over the past 5 years, Arcus Biosciences' Gross Profit (Quarterly) stood at $354.6 million in 2021, then plummeted by 90.41% to $34.0 million in 2022, then declined by 8.82% to $31.0 million in 2023, then dropped by 16.13% to $26.0 million in 2024, then slumped by 45.83% to $26.0 million in 2025.
  • Its Gross Profit was $26.0 million in Q3 2025, compared to $160.0 million in Q2 2025 and $28.0 million in Q1 2025.